Arlo Reports Second Quarter 2022 Results
Q2 ARR ended at $117 million, growing 67% year over year Revenue Growth of 20.7%…
Q2 ARR ended at $117 million, growing 67% year over year Revenue Growth of 20.7%…
Named an overall leader for six consecutive years, Domo also received a 100% recommend score…
– Produced 74 vehicles and powertrains during the quarter, up from 40 in the prior…
ATLANTA–(BUSINESS WIRE)–Angel Oak Mortgage, Inc. (NYSE: AOMR) (the “Company,” “we,” and “our”), a leading real…
Total Revenue Grew 10% Year-over-Year Adjusted EBITDA Grew 36% Year-over-Year SAN MATEO, Calif.–(BUSINESS WIRE)–Model N,…
Unity delivered $297.0 million in revenue during the second quarter of 2022, up 9% year-over-year…
BAINBRIDGE, Ga.–(BUSINESS WIRE)–Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer” or the “Company”), a leading next generation…
Second quarter contract revenue year-over-year growth of 19.7% to $26.8 million Second quarter total revenue…
Revenue increased 38% year over year to $107.9 million for the second quarter of 2022…
Company Achieves Upper End Q1 Fiscal 2023 Revenue Guidance and Beats Adjusted EBITDA Guidance Direct…
– Q2 Revenue Up 78% Year Over Year – – Q2 Software and Managed Services…
SAN JOSE, Calif.–(BUSINESS WIRE)–Super Micro Computer, Inc. (Nasdaq: SMCI), a global leader in high-performance, high-efficiency…
PDUFA date of September 8, 2022 for DaxibotulinumtoxinA for Injection in glabellar lines Reinspection of…
Q2 Revenue of $3.9 million Company pays off in full its $19.2 million outstanding loan…
Revenue of $91.4 million, up 4.3% from Q2 2021 Net loss of $5.1 million versus…
INSIDE INFORMATION The acquisition will result in the business combination of Bone Therapeutics and Medsenic…
DALLAS, Aug. 09, 2022 (GLOBE NEWSWIRE) — Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a patient-centric,…
SAN DIEGO, Aug. 09, 2022 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnology…
SALINAS, Calif., Aug. 09, 2022 (GLOBE NEWSWIRE) — Lowell Farms Inc. (the “Company”) (CSE: LOWL;…
Achieved Record Q2 2022 FIRDAPSE® Net Product Revenues of $53.0 Million, a 57.7% YoY Increase…